JPS6112675B2 - - Google Patents
Info
- Publication number
- JPS6112675B2 JPS6112675B2 JP10206680A JP10206680A JPS6112675B2 JP S6112675 B2 JPS6112675 B2 JP S6112675B2 JP 10206680 A JP10206680 A JP 10206680A JP 10206680 A JP10206680 A JP 10206680A JP S6112675 B2 JPS6112675 B2 JP S6112675B2
- Authority
- JP
- Japan
- Prior art keywords
- aso
- ascorbic acid
- solution
- enzyme
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 19
- 235000010323 ascorbic acid Nutrition 0.000 claims description 11
- 229960005070 ascorbic acid Drugs 0.000 claims description 11
- 239000011668 ascorbic acid Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 6
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 230000000087 stabilizing effect Effects 0.000 claims description 5
- 102000004316 Oxidoreductases Human genes 0.000 claims description 3
- 108090000854 Oxidoreductases Proteins 0.000 claims description 3
- 239000000203 mixture Substances 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 240000008067 Cucumis sativus Species 0.000 description 5
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 235000000832 Ayote Nutrition 0.000 description 4
- 235000009854 Cucurbita moschata Nutrition 0.000 description 4
- 240000001980 Cucurbita pepo Species 0.000 description 4
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000015136 pumpkin Nutrition 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000219104 Cucurbitaceae Species 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- -1 alkali metal salt Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- AENYAMPVQFAKHY-UHFFFAOYSA-N boric acid;potassium Chemical compound [K].OB(O)O AENYAMPVQFAKHY-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Description
本発明はアスコルビン酸酸化酵素
〔EC1.1033〕(以下ASOと略する)の安定化法に
関する。
ASOは古くから種々の高等植物に所在するこ
とが知られており、特に該酵素含量の高いキウリ
やカボチヤ等のウリ科植物の果実皮を給源にして
の研究が盛んに行われ、これ迄、ASOの性質に
関して詳細に検討され、報告されている。近年、
その精製品は臨床検査分野において、アスコルビ
ン酸の定量に、あるいは検体中のアスコルビン酸
が測定系に影響を与える場合に、かかる系に
ASOを供存せしめ、アスコルビン酸を酸化分解
して、その防害を排除する手法が一般化されてい
る。しかしながらASOは乾燥した製剤状態にお
いて不安定であることから、該酵素の安定な市販
製剤の開発が強く望まれている。
本発明者等はかかる難点を解決し、充分に貯蔵
安定である安定化ASO製剤を得るべく種々検討
を行つた。その結果、アルギニン、リジン、ヒス
チジンおよびホウ酸塩から選ばれた1種もしくは
2種以上の化合物をASO製剤中に含有せしめる
ことにより、著しくは安定性が向上することを見
出し、本発明を完成するに到つた。すなわち、本
発明はASO製剤にアルギニン、リジン、ヒスチ
ジンおよびホウ酸塩からなる群から選ばれた1種
もしくは2種以上の化合物を含有させることを特
徴とするASOの安定化法である。
本発明におけるASO製剤とはキウリあるいは
カボチヤなどから分離され、乾燥された固体状の
ASOを意味する。このASO製剤は高度に精製さ
れたものに限定されない。
本発明の安定化剤はアルギニン、リジン、ヒス
チジンおよびホウ酸塩からなる群から選ばれた1
種もしくは2種以上の化合物であり、ホウ酸塩は
ホウ酸のナトリウム、カリウムなどのアルカリ金
属塩などを意味する。
安定化剤の配合割合はASO製剤100重量部当り
10〜1000重量部である。
安定化剤を含有するASO製剤を得るには、
ASO溶液と安定化剤を配合する工程と、この混
合物を乾燥する工程とからなる。ASO溶液は、
ASOと緩衝液に溶解させた、好ましくは濃度0.5
〜5重量%、PH6.5〜9.5の溶液である。安定化剤
はこのASO溶液に直接に、あるいは緩衝液もし
くは水に溶解して配合させる。この混合物を乾燥
して製剤化する手段は常法に従う。例えば凍結乾
燥あるいは噴霧乾燥などを行う。
本発明の安定化法に従えば、ASOを製剤化す
るときの安定化が極めて大きく、また得られた
ASO製剤は長期間に亘つて安定である。
なお本発明で使用するASOの酵素活性は以下
の方法で測定する。
(1) 反応液の組成
1mMアスコルビン酸溶液(0.2Mリン酸1カ
リウム及び1mMエチレンジアミンテトラ酢
酸・2ナトリウム塩を含む) 0.5m1
0.01Mリン酸2ナトリウム溶液 0.5m1
酵素液(0.04〜0.3単位/mlに0.05%牛血清ア
ルブミンを含む0.01Mリン酸2ナトリウム溶
液で希釈) 0.1ml
(2) 反応条件及び酵素力価
30℃、5分間反応する。反応停止は0.2N塩
酸、3.0m1添加で行い、分解されたアスコルビ
ン酸量を245nmの吸光度の減少量から求める。
即ち、アスコルビン酸の上記条件下における
245nmでの分子吸光係数として(ε−10×
10-3)を用い、反応時の245nmにおける吸光度
の減少量から分解されたアスコルビン酸量を求
め、これをもとにして試料中の酵素力価を算出
する。
酵素力価の表示は、上記条件下で1分間に1
μモルのアスコルビン酸が分解される酵素量を
1単位として行う。
以下実施例により本発明を詳細に説明する。
実施例 1
キウリ及びカボチヤ由来のASO〔キウリ由来
(比活性(単位/OD280):910)、カボチヤ由来
(比活性(単位/OD280):500)〕を各々0.01Mリ
ン酸緩衝液(PH8.0)で1ml当りの固形分を20mg
になる様に調整した。第1表に示される化合物を
同じ緩衝液で2%(W/V)溶液となしたものを
上記酵素液に1mlずつ添加して、5ml容バイアル
瓶にて凍結乾燥した。乾燥直後および更にその乾
燥製品を40℃で4日間保存した場合の酵素活性の
残存率を測定した。その結果を第1表に示す。
第1表から明らかなように、いずれのASO製
剤も無添加に比べ、アルギニン、リジン、ヒスチ
ジンあるいはホウ酸ナトリウムの添加で、凍結乾
燥収率およびその後の保存安定性のいずれもが著
しく向上した。
The present invention relates to a method for stabilizing ascorbic acid oxidase [EC1.1033] (hereinafter abbreviated as ASO). ASO has long been known to be present in various higher plants, and much research has been carried out using the fruit peels of Cucurbitaceae plants, such as cucumber and pumpkin, which have a high content of the enzyme. The properties of ASO have been discussed and reported in detail. recent years,
The purified product is used in the field of clinical testing to quantify ascorbic acid, or when ascorbic acid in a sample affects the measurement system.
A commonly used method is to provide ASO and oxidize and decompose ascorbic acid to eliminate its harmful effects. However, since ASO is unstable in a dry formulation state, there is a strong desire to develop a stable commercial formulation of this enzyme. The present inventors have conducted various studies in order to solve these difficulties and obtain a stabilized ASO formulation that is sufficiently storage stable. As a result, the present inventors have discovered that stability can be significantly improved by incorporating one or more compounds selected from arginine, lysine, histidine, and borate into an ASO formulation, and have completed the present invention. I reached it. That is, the present invention is a method for stabilizing ASO, which is characterized in that the ASO preparation contains one or more compounds selected from the group consisting of arginine, lysine, histidine, and borate. The ASO preparation in the present invention is a solid product separated from cucumber or pumpkin and dried.
means ASO. This ASO preparation is not limited to highly purified products. The stabilizer of the present invention is selected from the group consisting of arginine, lysine, histidine and borate.
It is a species or a compound of two or more kinds, and borate refers to an alkali metal salt such as sodium or potassium boric acid. The blending ratio of stabilizer is per 100 parts by weight of ASO formulation.
10 to 1000 parts by weight. To obtain ASO formulations containing stabilizers,
It consists of a step of blending the ASO solution and a stabilizer, and a step of drying this mixture. The ASO solution is
ASO and dissolved in buffer, preferably at a concentration of 0.5
-5% by weight, pH 6.5-9.5 solution. The stabilizer is added to the ASO solution directly or dissolved in a buffer or water. The method for drying this mixture to form a formulation follows a conventional method. For example, freeze drying or spray drying is performed. According to the stabilization method of the present invention, the stabilization when formulating ASO is extremely large, and the obtained
ASO formulations are stable over long periods of time. The enzymatic activity of ASO used in the present invention is measured by the following method. (1) Composition of reaction solution 1mM ascorbic acid solution (contains 0.2M monopotassium phosphate and 1mM ethylenediaminetetraacetic acid disodium salt) 0.5m1 0.01M disodium phosphate solution 0.5m1 Enzyme solution (0.04-0.3 units/ml) (diluted with 0.01M disodium phosphate solution containing 0.05% bovine serum albumin) 0.1ml (2) Reaction conditions and enzyme titer React at 30℃ for 5 minutes. The reaction is stopped by adding 3.0ml of 0.2N hydrochloric acid, and the amount of decomposed ascorbic acid is determined from the decrease in absorbance at 245nm.
That is, under the above conditions of ascorbic acid
As the molecular extinction coefficient at 245 nm (ε−10×
10 -3 ), determine the amount of decomposed ascorbic acid from the decrease in absorbance at 245 nm during the reaction, and calculate the enzyme titer in the sample based on this. The enzyme titer is displayed at 1 minute per minute under the above conditions.
The amount of enzyme that decomposes μmol of ascorbic acid is taken as one unit. The present invention will be explained in detail below with reference to Examples. Example 1 ASO derived from cucumber and pumpkin [derived from cucumber (specific activity (unit/OD 280 ): 910) and derived from pumpkin (specific activity (unit/OD 280 ): 500)] were each added to 0.01 M phosphate buffer (PH8). .0) with a solid content of 20mg per ml.
I adjusted it so that A 2% (W/V) solution of the compounds shown in Table 1 in the same buffer was added to the above enzyme solution in 1 ml portions and freeze-dried in a 5 ml vial. The residual rate of enzyme activity was measured immediately after drying and when the dried product was further stored at 40°C for 4 days. The results are shown in Table 1. As is clear from Table 1, both the freeze-drying yield and the subsequent storage stability were significantly improved by the addition of arginine, lysine, histidine, or sodium borate compared to the case where no ASO preparations were added.
【表】
実施例 2
キウリ由来のASO〔比活性(単位/OD280):
910〕を用いて、更に実施例1と同様に操作して
凍結乾燥品を調製し、アルギニン、リジン、ヒス
チジンあるいはホウ酸塩の添加濃度水準およびそ
れらの組み合せ併用による安定化効果の検討を行
つた。その結果を第2表に示す。
第2表から明らかなように、いずれの添加物も
少なくとも10〜90重量%の添加で著しい安定化効
果を示した。また、それらの添加物の組み合せ併
用においても各々の添加物単独の場合と同様に著
しい保存安定性の向上が認められた。[Table] Example 2 ASO derived from cucumber [specific activity (unit/OD 280 ):
910] and further operated in the same manner as in Example 1 to prepare a lyophilized product, and the concentration levels of arginine, lysine, histidine, or borate and the stabilizing effects of their combinations were investigated. . The results are shown in Table 2. As is clear from Table 2, all additives exhibited a significant stabilizing effect when added at least 10 to 90% by weight. Also, when these additives were used in combination, a significant improvement in storage stability was observed as in the case of each additive alone.
【表】【table】
【表】
凍結乾燥品重量
[Table] Freeze-dried product weight
Claims (1)
リジン、ヒスチジンおよびホウ酸塩からなる群か
ら選ばれた1種もしくは2種以上の化合物を含有
させることを特徴とするアスコルビン酸酸化酵素
の安定化法。1 Arginine in ascorbic acid oxidase preparation,
1. A method for stabilizing ascorbic acid oxidase, which comprises containing one or more compounds selected from the group consisting of lysine, histidine, and borate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10206680A JPS5726587A (en) | 1980-07-24 | 1980-07-24 | Stabilization of ascorbic acid oxidase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10206680A JPS5726587A (en) | 1980-07-24 | 1980-07-24 | Stabilization of ascorbic acid oxidase |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5726587A JPS5726587A (en) | 1982-02-12 |
JPS6112675B2 true JPS6112675B2 (en) | 1986-04-09 |
Family
ID=14317385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10206680A Granted JPS5726587A (en) | 1980-07-24 | 1980-07-24 | Stabilization of ascorbic acid oxidase |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5726587A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61242579A (en) * | 1985-04-22 | 1986-10-28 | Amano Pharmaceut Co Ltd | Stable ascorbic acid oxidase composition |
JP2558450B2 (en) * | 1986-03-13 | 1996-11-27 | 和光純薬工業株式会社 | Method for stabilizing xanthine oxidase |
US5405767A (en) * | 1992-04-08 | 1995-04-11 | Solvay Enzymes, Inc. | Purified enzyme concentrate and method of preparation |
JPH05244948A (en) * | 1992-08-07 | 1993-09-24 | Amano Pharmaceut Co Ltd | Method for stabilizing ascorbic oxidase |
US5656730A (en) * | 1995-04-07 | 1997-08-12 | Enzon, Inc. | Stabilized monomeric protein compositions |
JP3708212B2 (en) * | 1996-04-17 | 2005-10-19 | 三井化学株式会社 | Concentration method of acrylamide aqueous solution |
-
1980
- 1980-07-24 JP JP10206680A patent/JPS5726587A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5726587A (en) | 1982-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100491281B1 (en) | Stabilized Albumin-Free Recombinant Factor Ⅷ Preparation having a Low Sugar Content | |
KR100417593B1 (en) | Dry blood factor composition containing trehalose | |
Chilson et al. | Studies on the mechanism of hybridization of lactic dehydrogenases in vitro | |
KR920003331B1 (en) | Injectable composition contains spergualin of making method | |
JPS6310686B2 (en) | ||
FR2591485A1 (en) | STABILIZED COMPOSITIONS CONTAINING THE PLASMINOGEN ACTIVATOR OF HUMAN TISSUE | |
US7253262B2 (en) | Dried blood factor composition comprising trehalose | |
US3758683A (en) | Insulin product | |
US5028587A (en) | Mixed crystals of insulin and insulin derivatives | |
Welling et al. | Disturbance of oxidative phosphorylation by an antibioticum produced by pseudomonas cocovenenans | |
JPS6112675B2 (en) | ||
EP0244315B1 (en) | Process for preparing an aquous pharmaceutical solution of an organic acid as the active ingredient | |
BACILA et al. | The effect of adrenal cortical hormones on the anaerobic glycolysis and hexokinase activity | |
Owren | The fifth coagulation factor (Factor V'). Preparation and properties | |
EP0134568A1 (en) | Stable antibacterial lyophilizates | |
Repaske | Succinic dehydrogenase of Azotobacter vinelandii | |
JPS6123995B2 (en) | ||
JPH05306235A (en) | Stabilized composition of parathyroid hormones | |
TAKAHASHI et al. | Structure of Lysozyme X. On the Structural Role of Tryptophan Residues | |
JP2971680B2 (en) | Composition containing tissue plasminogen activator | |
JPH0150209B2 (en) | ||
JP2739584B2 (en) | Urokinase-type plasminogen activator dry preparation | |
JPS61242579A (en) | Stable ascorbic acid oxidase composition | |
JPS62228272A (en) | Stable peroxidase formulation | |
JPH05244948A (en) | Method for stabilizing ascorbic oxidase |